Please login to the form below

Not currently logged in
Email:
Password:

Tredaptive

This page shows the latest Tredaptive news and features for those working in and with pharma, biotech and healthcare.

FDA rejects Merck muscle relaxant drug once again

FDA rejects Merck muscle relaxant drug once again

this year after disappointments such as the failure of cholesterol drug Tredaptive (extended-release niacin/laropiprant).

Latest news

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Closing the treatment gap

    This included a global release available at the press event and distribution over the wires, a glossy media guide to cardiovascular disease, fact sheets on heart disease, Merck’s drug Tredaptive

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...